US stock futures higher as investors scrutinize earnings
After the close, auto maker Rivian, Skyworks Solutions, social media company Snap, semiconductor giant AMD, Opendoor, Arista Networks, and Super Micro were among the companies that reported quarterly results.
At 6:10 a.m. ET, futures linked to the blue-chip Dow rose 0.31%, while broad S&P 500 futures added 0.22% and tech-laden Nasdaq futures gained 0.04%.
Corporate news
Cryptocurrency
The Securities and Exchange Commission said liquid staking activities aren't securities under federal law.
Liquid staking refers to the process of staking crypto assets through a third party and receiving a 'liquid staking receipt token' to show the, staker's ownership of the staked crypto assets and any rewards that accrue to them.
Medora Lee is a money, markets, and personal finance reporter at USA TODAY. You can reach her at mjlee@usatoday.com and subscribe to our free Daily Money newsletter for personal finance tips and business news every Monday through Friday morning.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
ProQR Therapeutics Second Quarter 2025 Earnings: Misses Expectations
Explore ProQR Therapeutics's Fair Values from the Community and select yours ProQR Therapeutics (NASDAQ:PRQR) Second Quarter 2025 Results Key Financial Results Revenue: €3.98m (down 39% from 2Q 2024). Net loss: €12.2m (loss widened by 352% from 2Q 2024). €0.12 loss per share (further deteriorated from €0.033 loss in 2Q 2024). This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period ProQR Therapeutics Revenues and Earnings Miss Expectations Revenue missed analyst estimates by 7.7%. Earnings per share (EPS) also missed analyst estimates by 50%. Looking ahead, revenue is forecast to grow 50% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Biotechs industry in the US. Performance of the American Biotechs industry. The company's shares are up 4.3% from a week ago. Risk Analysis Before you take the next step you should know about the 2 warning signs for ProQR Therapeutics that we have uncovered. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
17 minutes ago
- Yahoo
DLH Holdings Third Quarter 2025 Earnings: In Line With Expectations
Explore DLH Holdings's Fair Values from the Community and select yours DLH Holdings (NASDAQ:DLHC) Third Quarter 2025 Results Key Financial Results Revenue: US$83.3m (down 17% from 3Q 2024). Net income: US$289.0k (down 75% from 3Q 2024). Profit margin: 0.3% (down from 1.1% in 3Q 2024). The decrease in margin was driven by lower revenue. EPS: US$0.02 (down from US$0.08 in 3Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period DLH Holdings Earnings Insights Looking ahead, revenue is expected to decline by 21% p.a. on average during the next 2 years, while revenues in the Professional Services industry in the US are expected to grow by 5.9%. Performance of the American Professional Services industry. The company's share price is broadly unchanged from a week ago. Risk Analysis What about risks? Every company has them, and we've spotted 3 warning signs for DLH Holdings (of which 2 don't sit too well with us!) you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
17 minutes ago
- Yahoo
Sezzle Second Quarter 2025 Earnings: Beats Expectations
Sezzle (NASDAQ:SEZL) Second Quarter 2025 Results Key Financial Results Revenue: US$98.7m (up 76% from 2Q 2024). Net income: US$27.6m (down 7.1% from 2Q 2024). Profit margin: 28% (down from 53% in 2Q 2024). EPS: US$0.82 (down from US$0.88 in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period Sezzle Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 4.0%. Earnings per share (EPS) also surpassed analyst estimates by 34%. Looking ahead, revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Diversified Financial industry in the US. Performance of the American Diversified Financial industry. The company's shares are down 36% from a week ago. Risk Analysis Be aware that Sezzle is showing 3 warning signs in our investment analysis and 1 of those is concerning... Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
